Legal & General Group Plc - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 207 filers reported holding DENALI THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,183,170
-29.5%
105,825
+0.9%
0.00%0.0%
Q2 2023$3,095,364
+37.6%
104,892
+7.5%
0.00%0.0%
Q1 2023$2,249,120
-14.9%
97,618
+2.7%
0.00%0.0%
Q4 2022$2,642,365
+0.1%
95,015
+10.5%
0.00%0.0%
Q3 2022$2,640,000
+3.7%
86,017
-0.6%
0.00%0.0%
Q2 2022$2,546,000
-0.4%
86,503
+8.9%
0.00%0.0%
Q1 2022$2,555,000
-27.5%
79,426
+0.6%
0.00%0.0%
Q4 2021$3,523,000
-9.9%
78,971
+1.9%
0.00%0.0%
Q3 2021$3,911,000
-19.9%
77,528
+24.6%
0.00%
-50.0%
Q2 2021$4,883,000
+96.3%
62,244
+42.9%
0.00%
+100.0%
Q1 2021$2,487,000
-33.9%
43,550
-3.0%
0.00%0.0%
Q4 2020$3,761,000
+165.2%
44,897
+13.4%
0.00%0.0%
Q3 2020$1,418,000
+68.8%
39,586
+13.9%
0.00%
Q2 2020$840,000
+82.6%
34,754
+32.3%
0.00%
Q1 2020$460,000
-4.6%
26,278
-5.0%
0.00%
Q4 2019$482,000
+22.0%
27,659
+7.2%
0.00%
Q3 2019$395,000
-26.3%
25,7980.0%0.00%
Q2 2019$536,000
-8.7%
25,798
+1.9%
0.00%
Q1 2019$587,000
+227.9%
25,308
+193.0%
0.00%
Q4 2018$179,000
+10.5%
8,638
+16.3%
0.00%
Q3 2018$162,000
-23.9%
7,426
-46.9%
0.00%
Q2 2018$213,000
-79.1%
13,980
-73.0%
0.00%
-100.0%
Q1 2018$1,018,000
+101700.0%
51,736
+93965.5%
0.00%
Q4 2017$1,000550.00%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Crestline Management, LP 7,705,039$343,645,00025.68%
Casdin Capital, LLC 1,500,000$66,900,0001.89%
Flagship Pioneering Inc. 2,619,968$116,851,0001.81%
SECTORAL ASSET MANAGEMENT INC 189,600$8,456,0001.27%
Integral Health Asset Management, LLC 100,000$4,460,0001.23%
Temasek Holdings (Private) Ltd 5,369,487$239,479,0000.86%
Goldstream Capital Management Ltd 78,418$3,497,0000.86%
Yiheng Capital Management, L.P. 335,184$14,949,0000.76%
GILDER GAGNON HOWE & CO LLC 2,900,114$129,345,0000.74%
Artal Group S.A. 600,000$26,760,0000.73%
View complete list of DENALI THERAPEUTICS INC shareholders